Patents by Inventor Junko Hashino

Junko Hashino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6689749
    Abstract: The invention provides a peptide capable of blocking voltage-gated K+ channels and inhibiting IL-2 production, which is represented by an amino acid sequence of: Ala-Ser-Cys-Arg-Thr-Pro-Lys-Asp-Cys-Ala-Asp-Pro-Cys-Arg-Lys-Glu-Thr-Gly-Cys-Pro-Tyr-Gly-Lys-Cys-Met-Asn-Arg-Lys-Cys-Lys-Cys-Asn-Arg-Cys; in which the C-terminal is amidated and four disulfide bridges are present in the molecule, and their related peptides isolated from the venom gland of a scorpion Heterometrus spinnifer. The peptides provided by the present invention are neuropeptides which can block voltage-gated K+ channels and inhibit IL-2 production at an extremely low concentration and, therefore, are expected to contribute to application of scorpion toxins to medicines and so on.
    Type: Grant
    Filed: August 26, 1998
    Date of Patent: February 10, 2004
    Assignee: Suntory Limited
    Inventors: Bruno Lebrun, RĂ©gine Romi-Lebrun, Hiroyuki Minakata, Terumi Nakajima, Junko Hashino
  • Patent number: 6040335
    Abstract: Compounds represented by the general formula (I) or pharmacologically acceptable salts thereof: ##STR1## (where R is a group --NHCHR.sub.1 R.sub.2, --N(CHR.sub.1 R.sub.2).sub.2, --N(CHR.sub.1 R.sub.2)CHR.sub.3 R.sub.4, --N.sup.+ (CHR.sub.1 R.sub.2).sub.3, --N.sup.+ (CHR.sub.1 R.sub.2).sub.2 CHR.sub.3 R.sub.4 or --N.sup.+ (CHR.sub.1 R.sub.2)(CHR.sub.3 R.sub.4)CHR.sub.5 R.sub.6 (where R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6, which may be the same or different, are each a hydrogen atom, an alkyl group, an alkenyl group, an aryl group or an aralkyl group, or an alkyl, alkenyl, aryl or aralkyl group which is substituted by at least one substituent selected from the group consisting of a halogen atom, a hydroxyl group, a lower alkoxy group, a lower alkylacyloxy group, a lower alkylacyl group, a lower alkoxycarbonyl group, a nitro group, a cyano group and a heterocyclic group, with CHR.sub.1 R.sub.2, CHR.sub.3 R.sub.4 or CHR.sub.5 R.sub.
    Type: Grant
    Filed: July 31, 1997
    Date of Patent: March 21, 2000
    Assignee: Suntory Limited
    Inventors: Masayuki Saitoh, Yasuo Kitajima, Norio Iwasawa, Kenju Miura, Munetada Haruyama, Junko Hashino
  • Patent number: 5648078
    Abstract: The metastasis of cells, which express a glycoprotein of human carcinoembryonic antigen on the cells surfaces, is inhibited in a living organ by administering, in advance, to a subject, a monoclonal antibody which binds a peptide which comprises at least the peptide sequence of domain N in the glycoprotein of human carcinoembryonic antigen.
    Type: Grant
    Filed: May 11, 1994
    Date of Patent: July 15, 1997
    Assignee: Suntory Limited
    Inventors: Junko Hashino, Shinzo Oikawa, Hiroshi Nakazato, Toshihiro Nakanishi